Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

LRRK2 regulation of immune-pathways and inflammatory disease.

Wallings RL, Tansey MG.

Biochem Soc Trans. 2019 Nov 26. pii: BST20180463. doi: 10.1042/BST20180463. [Epub ahead of print]

PMID:
31769472
2.

Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.

Wallings RL, Humble SW, Ward ME, Wade-Martins R.

Trends Neurosci. 2019 Dec;42(12):899-912. doi: 10.1016/j.tins.2019.10.002. Epub 2019 Nov 5. Review.

PMID:
31704179
3.

LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function.

Wallings R, Connor-Robson N, Wade-Martins R.

Hum Mol Genet. 2019 Aug 15;28(16):2696-2710. doi: 10.1093/hmg/ddz088.

4.

LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function.

Sloan M, Alegre-Abarrategui J, Potgieter D, Kaufmann AK, Exley R, Deltheil T, Threlfell S, Connor-Robson N, Brimblecombe K, Wallings R, Cioroch M, Bannerman DM, Bolam JP, Magill PJ, Cragg SJ, Dodson PD, Wade-Martins R.

Hum Mol Genet. 2016 Mar 1;25(5):951-63. doi: 10.1093/hmg/ddv628. Epub 2016 Jan 6.

5.

Cellular processes associated with LRRK2 function and dysfunction.

Wallings R, Manzoni C, Bandopadhyay R.

FEBS J. 2015 Aug;282(15):2806-26. doi: 10.1111/febs.13305. Epub 2015 May 9. Review.

Supplemental Content

Loading ...
Support Center